
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
Liyang Fei, Xiaochen Ren, Haijia Yu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 148
Liyang Fei, Xiaochen Ren, Haijia Yu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 148
Showing 1-25 of 148 citing articles:
Macrophage diversity in cancer revisited in the era of single-cell omics
Ruoyu Ma, Annabel Black, Bin‐Zhi Qian
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 546-563
Open Access | Times Cited: 355
Ruoyu Ma, Annabel Black, Bin‐Zhi Qian
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 546-563
Open Access | Times Cited: 355
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts
Yixin Zheng, Kai Wei, Ping Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 32
Yixin Zheng, Kai Wei, Ping Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 32
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells
Yibi Zhang, Xiaodong Wang, Yinmin Gu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 4
Open Access | Times Cited: 2
Yibi Zhang, Xiaodong Wang, Yinmin Gu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 4
Open Access | Times Cited: 2
Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion
Kyung-Pil Ko, Yuanjian Huang, Shengzhe Zhang, et al.
Gastroenterology (2023) Vol. 165, Iss. 3, pp. 613-628.e20
Open Access | Times Cited: 39
Kyung-Pil Ko, Yuanjian Huang, Shengzhe Zhang, et al.
Gastroenterology (2023) Vol. 165, Iss. 3, pp. 613-628.e20
Open Access | Times Cited: 39
Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity
Mark Sorin, Elham Karimi, Morteza Rezanejad, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005545-e005545
Open Access | Times Cited: 37
Mark Sorin, Elham Karimi, Morteza Rezanejad, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005545-e005545
Open Access | Times Cited: 37
The role of p53 in anti-tumor immunity and response to immunotherapy
Lindsey Carlsen, Shengliang Zhang, Xiaobing Tian, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 37
Lindsey Carlsen, Shengliang Zhang, Xiaobing Tian, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 37
Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy
SriPragnya Cheruku, Vanishree Rao, Ruchi Pandey, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109569-109569
Closed Access | Times Cited: 32
SriPragnya Cheruku, Vanishree Rao, Ruchi Pandey, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109569-109569
Closed Access | Times Cited: 32
Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden
Mingrui Zhu, Jiwoong Kim, Qing Deng, et al.
Cancer Cell (2023) Vol. 41, Iss. 10, pp. 1731-1748.e8
Open Access | Times Cited: 30
Mingrui Zhu, Jiwoong Kim, Qing Deng, et al.
Cancer Cell (2023) Vol. 41, Iss. 10, pp. 1731-1748.e8
Open Access | Times Cited: 30
Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development
Jacinth Wing‐Sum Cheu, David Kung‐Chun Chiu, Kenneth Kin‐Leung Kwan, et al.
Science Advances (2023) Vol. 9, Iss. 18
Open Access | Times Cited: 26
Jacinth Wing‐Sum Cheu, David Kung‐Chun Chiu, Kenneth Kin‐Leung Kwan, et al.
Science Advances (2023) Vol. 9, Iss. 18
Open Access | Times Cited: 26
Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy
Paulina Czajka‐Francuz, Maria J. Prendes, Arun K. Mankan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 24
Paulina Czajka‐Francuz, Maria J. Prendes, Arun K. Mankan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 24
Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer
Na Song, Kai Cui, Liqun Zeng, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176357-176357
Closed Access | Times Cited: 14
Na Song, Kai Cui, Liqun Zeng, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176357-176357
Closed Access | Times Cited: 14
The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine
Sabina Pozzi, Ronit Satchi‐Fainaro
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115318-115318
Closed Access | Times Cited: 14
Sabina Pozzi, Ronit Satchi‐Fainaro
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115318-115318
Closed Access | Times Cited: 14
NEIL1 drives the initiation of colorectal cancer through transcriptional regulation of COL17A1
Jinghua Cao, Chenhui Cao, Jin‐Long Lin, et al.
Cell Reports (2024) Vol. 43, Iss. 1, pp. 113654-113654
Open Access | Times Cited: 13
Jinghua Cao, Chenhui Cao, Jin‐Long Lin, et al.
Cell Reports (2024) Vol. 43, Iss. 1, pp. 113654-113654
Open Access | Times Cited: 13
The Roles of Myeloid Cells in Breast Cancer Progression
Charlotte Helena Rivas, Fengshuo Liu, Xiang H.-F. Zhang
Advances in experimental medicine and biology (2025), pp. 397-412
Closed Access | Times Cited: 1
Charlotte Helena Rivas, Fengshuo Liu, Xiang H.-F. Zhang
Advances in experimental medicine and biology (2025), pp. 397-412
Closed Access | Times Cited: 1
Tumour‐Associated Macrophages in Oral Squamous Cell Carcinoma
Akhilanand Chaurasia, Carel Brigi, Arwa Daghrery, et al.
Oral Diseases (2025)
Closed Access | Times Cited: 1
Akhilanand Chaurasia, Carel Brigi, Arwa Daghrery, et al.
Oral Diseases (2025)
Closed Access | Times Cited: 1
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Francesco De Sanctis, Annalisa Adamo, Stefania Canè, et al.
Seminars in Immunopathology (2022) Vol. 45, Iss. 2, pp. 163-186
Open Access | Times Cited: 35
Francesco De Sanctis, Annalisa Adamo, Stefania Canè, et al.
Seminars in Immunopathology (2022) Vol. 45, Iss. 2, pp. 163-186
Open Access | Times Cited: 35
Nesfatin-1 Stimulates CCL2-dependent Monocyte Migration And M1 Macrophage Polarization: Implications For Rheumatoid Arthritis Therapy
Jun‐Way Chang, Shan‐Chi Liu, Yen‐You Lin, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 281-293
Open Access | Times Cited: 30
Jun‐Way Chang, Shan‐Chi Liu, Yen‐You Lin, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 281-293
Open Access | Times Cited: 30
Liver-Targeted Delivery of Small Interfering RNA of C–C Chemokine Receptor 2 with Tetrahedral Framework Nucleic Acid Attenuates Liver Cirrhosis
Taoran Tian, Chong Zhao, Songhang Li, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 8, pp. 10492-10505
Closed Access | Times Cited: 22
Taoran Tian, Chong Zhao, Songhang Li, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 8, pp. 10492-10505
Closed Access | Times Cited: 22
Immunomodulation and immunopharmacology in heart failure
George Markousis‐Mavrogenis, Lukas Baumhove, Ali A. Al‐Mubarak, et al.
Nature Reviews Cardiology (2023) Vol. 21, Iss. 2, pp. 119-149
Closed Access | Times Cited: 22
George Markousis‐Mavrogenis, Lukas Baumhove, Ali A. Al‐Mubarak, et al.
Nature Reviews Cardiology (2023) Vol. 21, Iss. 2, pp. 119-149
Closed Access | Times Cited: 22
Epigenetic regulation and therapeutic targets in the tumor microenvironment
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 21
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 21
Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 21
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 21
Emerging functions of C/EBPβ in breast cancer
Megan G. Matherne, Emily S. Phillips, Samuel J. Embrey, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
Megan G. Matherne, Emily S. Phillips, Samuel J. Embrey, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18